Revita Life Sciences

Diabetes

Type 1 diabetes, also called juvenile diabetes, is an autoimmune disease that frequently presents itself from infancy to the late 30s For unknown reasons, the immune system sometimes launches an attack against the body’s own insulin-producing beta cells and destroys them. Nearly complete B-cell loss does characterize the final stages of the IDDM.

Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder of Insulin Resistance followed by Progressive and Inexorable β-cell dysfunction. The ultimate pathology is a failure of the pancreas to produce a sufficient amount of insulin to appropriately regulate glucose levels in the body.  At the time of diagnosis, almost 50% of β-cell mass is lost.

“TYPE 1 AND TYPE 2 DIABETES RESULT ENTIRELY OR IN PART FROM INADEQUATE NUMBERS OF NORMALLY FUNCTIONING PANCREATIC BETA CELLS.

IT THEREFORE FOLLOWS THAT RESTORATION OF NORMAL BETA CELL MASS AND FUNCTION SHOULD BE A VIABLE SOLUTION.”

Mesenchymal stem cells facilitate regeneration of pancreatic beta cells probably recruitment of progenitors of insulin-producing beta cells. Mscs also ameliorate Insulin Resistance  and  exert immunomodulatory effects

How It Is Done

As a day care procedure 120 ml of Bone marrow and 200 ml of fat is aspirated and processed in a closed system for stem cells isolation. 2 ml volume having at least 2-4 million stem cells per kg body weight is injected either into

Allogenic umbilical cord derived MScs may be needed in few cases

What To Expect

Type 1 diabetes

Type 2 diabetes

Revita Life Sciences values each patient’s uniqueness, providing tailored treatment plans for optimal, targeted care and support.

Office Hours

Daily – 9:30 am to 6:30 pm

Sunday – 08:00 am to 11:30 am

Holidays – 08:00 am to 3:00 pm

Contact Info

HB Specialty Hospital & Research Institute, Near Bhoorarani Gate, Kashipur Road, Rudrapur, Udham Singh Nagar, Uttarakhand, India 263153

+915944240234 +919897080188

Copyright © 2024. All Rights Reserved.